Amputation for extremity soft tissue sarcoma does not increase overall survival: A retrospective cohort study

V. K. Alamanda, S. N. Crosby, K. R. Archer, Y. Song, H. S. Schwartz, G. E. Holt

Research output: Contribution to journalArticle

Abstract

To determine if amputation increases survival when compared to limb salvage surgery in patients with a soft tissue sarcoma (STS) of the extremity when there is often a misconception among physicians and patients that ablative surgery eliminates local recurrence and increases overall survival. This retrospective cohort study assessed 278 patients with STS and compared 18 patients who had undergone amputations for soft tissue sarcomas of the extremities to a comparative cohort of 260 patients who underwent limb salvage surgery during the same time period. Our limb salvage surgery (LSS) rate was 94% overall for soft tissue sarcomas with a median follow-up of 3.1 years. Patients undergoing amputations either had tumors that involved a critical neurovascular bundle (in particular nerve rather than vessel resection was more responsible for a decision toward ablation), or underlying bone or had neoplasms whose large size would require such an enormous resection that a functional limb would not remain. In comparing prognostic effects, mainly death due to sarcoma, distant metastasis and local recurrence, it was found that there was no statistically significant difference between patients undergoing amputation to those undergoing limb salvage surgery (p > 0.05). While amputations do not increase overall survival in soft tissue sarcomas of the extremity as compared to LSS, they are still a valuable option in a surgeon's arsenal. In particular, amputations can provide improved local control and symptomatic treatment in patients who might not be candidates for limb salvage surgery.

Original languageEnglish (US)
Pages (from-to)1178-1183
Number of pages6
JournalEuropean Journal of Surgical Oncology
Volume38
Issue number12
DOIs
StatePublished - Dec 2012
Externally publishedYes

Fingerprint

Amputation
Sarcoma
Limb Salvage
Cohort Studies
Extremities
Retrospective Studies
Survival
Recurrence
Neoplasms
Neoplasm Metastasis
Physicians
Bone and Bones

Keywords

  • Amputation
  • Limb salvage
  • Local recurrence
  • Metastasis
  • Soft tissue sarcoma
  • Survival

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

Amputation for extremity soft tissue sarcoma does not increase overall survival : A retrospective cohort study. / Alamanda, V. K.; Crosby, S. N.; Archer, K. R.; Song, Y.; Schwartz, H. S.; Holt, G. E.

In: European Journal of Surgical Oncology, Vol. 38, No. 12, 12.2012, p. 1178-1183.

Research output: Contribution to journalArticle

Alamanda, V. K. ; Crosby, S. N. ; Archer, K. R. ; Song, Y. ; Schwartz, H. S. ; Holt, G. E. / Amputation for extremity soft tissue sarcoma does not increase overall survival : A retrospective cohort study. In: European Journal of Surgical Oncology. 2012 ; Vol. 38, No. 12. pp. 1178-1183.
@article{5e38f3936289471fa0c5e7e38fd762bc,
title = "Amputation for extremity soft tissue sarcoma does not increase overall survival: A retrospective cohort study",
abstract = "To determine if amputation increases survival when compared to limb salvage surgery in patients with a soft tissue sarcoma (STS) of the extremity when there is often a misconception among physicians and patients that ablative surgery eliminates local recurrence and increases overall survival. This retrospective cohort study assessed 278 patients with STS and compared 18 patients who had undergone amputations for soft tissue sarcomas of the extremities to a comparative cohort of 260 patients who underwent limb salvage surgery during the same time period. Our limb salvage surgery (LSS) rate was 94{\%} overall for soft tissue sarcomas with a median follow-up of 3.1 years. Patients undergoing amputations either had tumors that involved a critical neurovascular bundle (in particular nerve rather than vessel resection was more responsible for a decision toward ablation), or underlying bone or had neoplasms whose large size would require such an enormous resection that a functional limb would not remain. In comparing prognostic effects, mainly death due to sarcoma, distant metastasis and local recurrence, it was found that there was no statistically significant difference between patients undergoing amputation to those undergoing limb salvage surgery (p > 0.05). While amputations do not increase overall survival in soft tissue sarcomas of the extremity as compared to LSS, they are still a valuable option in a surgeon's arsenal. In particular, amputations can provide improved local control and symptomatic treatment in patients who might not be candidates for limb salvage surgery.",
keywords = "Amputation, Limb salvage, Local recurrence, Metastasis, Soft tissue sarcoma, Survival",
author = "Alamanda, {V. K.} and Crosby, {S. N.} and Archer, {K. R.} and Y. Song and Schwartz, {H. S.} and Holt, {G. E.}",
year = "2012",
month = "12",
doi = "10.1016/j.ejso.2012.08.024",
language = "English (US)",
volume = "38",
pages = "1178--1183",
journal = "European Journal of Surgical Oncology",
issn = "0748-7983",
publisher = "W.B. Saunders Ltd",
number = "12",

}

TY - JOUR

T1 - Amputation for extremity soft tissue sarcoma does not increase overall survival

T2 - A retrospective cohort study

AU - Alamanda, V. K.

AU - Crosby, S. N.

AU - Archer, K. R.

AU - Song, Y.

AU - Schwartz, H. S.

AU - Holt, G. E.

PY - 2012/12

Y1 - 2012/12

N2 - To determine if amputation increases survival when compared to limb salvage surgery in patients with a soft tissue sarcoma (STS) of the extremity when there is often a misconception among physicians and patients that ablative surgery eliminates local recurrence and increases overall survival. This retrospective cohort study assessed 278 patients with STS and compared 18 patients who had undergone amputations for soft tissue sarcomas of the extremities to a comparative cohort of 260 patients who underwent limb salvage surgery during the same time period. Our limb salvage surgery (LSS) rate was 94% overall for soft tissue sarcomas with a median follow-up of 3.1 years. Patients undergoing amputations either had tumors that involved a critical neurovascular bundle (in particular nerve rather than vessel resection was more responsible for a decision toward ablation), or underlying bone or had neoplasms whose large size would require such an enormous resection that a functional limb would not remain. In comparing prognostic effects, mainly death due to sarcoma, distant metastasis and local recurrence, it was found that there was no statistically significant difference between patients undergoing amputation to those undergoing limb salvage surgery (p > 0.05). While amputations do not increase overall survival in soft tissue sarcomas of the extremity as compared to LSS, they are still a valuable option in a surgeon's arsenal. In particular, amputations can provide improved local control and symptomatic treatment in patients who might not be candidates for limb salvage surgery.

AB - To determine if amputation increases survival when compared to limb salvage surgery in patients with a soft tissue sarcoma (STS) of the extremity when there is often a misconception among physicians and patients that ablative surgery eliminates local recurrence and increases overall survival. This retrospective cohort study assessed 278 patients with STS and compared 18 patients who had undergone amputations for soft tissue sarcomas of the extremities to a comparative cohort of 260 patients who underwent limb salvage surgery during the same time period. Our limb salvage surgery (LSS) rate was 94% overall for soft tissue sarcomas with a median follow-up of 3.1 years. Patients undergoing amputations either had tumors that involved a critical neurovascular bundle (in particular nerve rather than vessel resection was more responsible for a decision toward ablation), or underlying bone or had neoplasms whose large size would require such an enormous resection that a functional limb would not remain. In comparing prognostic effects, mainly death due to sarcoma, distant metastasis and local recurrence, it was found that there was no statistically significant difference between patients undergoing amputation to those undergoing limb salvage surgery (p > 0.05). While amputations do not increase overall survival in soft tissue sarcomas of the extremity as compared to LSS, they are still a valuable option in a surgeon's arsenal. In particular, amputations can provide improved local control and symptomatic treatment in patients who might not be candidates for limb salvage surgery.

KW - Amputation

KW - Limb salvage

KW - Local recurrence

KW - Metastasis

KW - Soft tissue sarcoma

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=84868380366&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868380366&partnerID=8YFLogxK

U2 - 10.1016/j.ejso.2012.08.024

DO - 10.1016/j.ejso.2012.08.024

M3 - Article

C2 - 22985713

AN - SCOPUS:84868380366

VL - 38

SP - 1178

EP - 1183

JO - European Journal of Surgical Oncology

JF - European Journal of Surgical Oncology

SN - 0748-7983

IS - 12

ER -